WealthShield Partners’s Idexx Laboratories IDXX Stock Holding History

WealthShield Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.46M	Sell	2,606 -35	-1%	-$22.4K	0.16%	150
2025 Q4	$1.79M	Sell	2,641 -5	-0.2%	-$3.4K	0.2%	125
2025 Q3	$1.69M	Sell	2,646 -100	-4%	-$60.7K	0.19%	129
2025 Q2	$1.47M	Buy	2,746 +1,468	+115%	+$702K	0.18%	133
2025 Q1	$537K	Sell	1,278 -4	-0.3%	-$1.74K	0.07%	214
2024 Q4	$530K	Buy	1,282 +2	+0.2%	+$877	0.08%	207
2024 Q3	$647K	Hold	1,280	–	–	0.09%	190
2024 Q2	$624K	Hold	1,280	–	–	0.1%	181
2024 Q1	$691K	Hold	1,280	–	–	0.11%	174
2023 Q4	$710K	Hold	1,280	–	–	0.12%	175
2023 Q3	$560K	Hold	1,280	–	–	0.08%	199
2023 Q2	$643K	Hold	1,280	–	–	0.1%	188
2023 Q1	$640K	Hold	1,280	–	–	0.1%	185
2022 Q4	$522K	Hold	1,280	–	–	0.1%	186
2022 Q3	$417K	Hold	1,280	–	–	0.08%	215
2022 Q2	$449K	Sell	1,280 -2,003	-61%	-$817K	0.09%	212
2022 Q1	$1.8M	Buy	+3,283	New	+$1.73M	0.29%	81
2021 Q2	–	Sell	-12	Closed	-$6K	–	936
2021 Q1	$6K	Buy	+12	New	+$6.01K	﹤0.01%	916

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WealthShield Partners's IDXX Position: Q1 2026 in Review

WealthShield Partners reduced its Idexx Laboratories (IDXX) stake by 1.3% in Q1 2026, selling an estimated $22.4K and leaving 2,606 shares worth $1.46M. The position accounts for 0.16% of the portfolio, ranked #150.

WealthShield Partners first reported a position in IDXX in Q1 2021 and has held it in 18 quarters since. The position peaked at $1.8M in Q1 2022. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

WealthShield Partners held 2,606 shares of Idexx Laboratories worth $1.46M as of Q1 2026.
WealthShield Partners sold 35 Idexx Laboratories shares in Q1 2026, an estimated $22.4K.
Idexx Laboratories made up 0.16% of WealthShield Partners's portfolio in Q1 2026, its #150 holding.
WealthShield Partners first reported a position in Idexx Laboratories in Q1 2021 and has held it in 18 quarters since.
WealthShield Partners's Idexx Laboratories position peaked at $1.8M in Q1 2022.
1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on WealthShield Partners's 13F filing for Q1 2026, filed 1 May 2026.